Published in Future Cardiol on January 01, 2011
GMP-conformant on-site manufacturing of a CD133(+) stem cell product for cardiovascular regeneration. Stem Cell Res Ther (2017) 0.97
Comparison of the therapeutic effects of bone marrow mononuclear cells and microglia for permanent cerebral ischemia. Behav Brain Res (2013) 0.88
The Clinical Status of Stem Cell Therapy for Ischemic Cardiomyopathy. Stem Cells Int (2015) 0.86
Exercise for the heart: signaling pathways. Oncotarget (2015) 0.85
Recent advances in the diagnosis and treatment of acute myocardial infarction. World J Cardiol (2015) 0.85
Mesenchymal stem cell transplantation for the infarcted heart: therapeutic potential for insulin resistance beyond the heart. Cardiovasc Diabetol (2013) 0.83
Focus on Extracellular Vesicles: Therapeutic Potential of Stem Cell-Derived Extracellular Vesicles. Int J Mol Sci (2016) 0.82
Mechanostimulation protocols for cardiac tissue engineering. Biomed Res Int (2013) 0.80
Immunotolerant Properties of Mesenchymal Stem Cells: Updated Review. Stem Cells Int (2015) 0.78
Ambient particulate matter exposure and cardiovascular diseases: a focus on progenitor and stem cells. J Cell Mol Med (2016) 0.76
Cardiac Repair and Regeneration: The Value of Cell Therapies. Eur Cardiol (2015) 0.76
Stacked stem cell sheets enhance cell-matrix interactions. Organogenesis (2014) 0.76
Adult vascular wall resident multipotent vascular stem cells, matrix metalloproteinases, and arterial aneurysms. Stem Cells Int (2015) 0.75
Exogenous connexin43-expressing autologous skeletal myoblasts ameliorate mechanical function and electrical activity of the rabbit heart after experimental infarction. Int J Exp Pathol (2014) 0.75